ZEB1-mediated biogenesis of circNIPBL sustains the metastasis of bladder cancer via Wnt/β-catenin pathway
Open Access
- 2 August 2023
- journal article
- research article
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 42 (1) , 1-16
Abstract
Background: Circular RNAs (circRNAs) circularized by back-splicing of pre-mRNA are widely expressed and affected the proliferation, invasion and metastasis of bladder cancer (BCa). However, the mechanism underlying circRNA biogenesis in mediating the distant metastasis of BCa still unexplored. Methods: RNA sequencing data between BCa and normal adjacent tissues was applied to identify the differentially expressed circRNAs. The functions of circNIPBL in BCa were investigated via a series of biochemical experiments. The Clinical significance of circNIPBL was examined in a cohort of larger BCa tissues. Results: In the present study, we identified a novel circRNA (hsa_circ_0001472), circNIPBL, which was significantly upregulated and had great influence on the poor prognosis of patients with BCa. Functionally, circNIPBL promotes BCa metastasis in vitro and in vivo. Mechanistically, circNIPBL upregulate the expression of Wnt5a and activated the Wnt/β-catenin signaling pathway via directly sponged miR-16-2-3p, leading to the upregulation of ZEB1, which triggers the EMT of BCa. Moreover, we revealed that ZEB1 interacted with the flanking introns of exons 2–9 on NIPBL pre-mRNA to trigger circNIPBL biogenesis, thus forming a positive feedback loop. Importantly, circNIPBL overexpression significantly facilitated the distant metastasis of BCa in the orthotopic bladder cancer model, while silencing ZEB1 remarkably blocked the effects of metastasis induced by circNIPBL overexpression. Conclusions: Our study highlights that circNIPBL-induced Wnt signaling pathway activation triggers ZEB1-mediated circNIPBL biogenesis, which forms a positive feedback loop via the circNIPBL/miR-16-2-3p/Wnt5a/ZEB1 axis, supporting circNIPBL as a novel therapeutic target and potential biomarker for BCa patients. GraphicalKeywords
Funding Information
- Key Technologies Research and Development Program (2022YFA1305500)
- National Natural Science Foundation of China (81825016)
This publication has 57 references indexed in Scilit:
- Epidemiology and Risk Factors of Urothelial Bladder CancerEuropean Urology, 2013
- Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compoundsMolecular Cancer, 2013
- ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular MarkersEuropean Urology, 2013
- Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder CancerScience Translational Medicine, 2012
- Bladder Cancer in 2010: How Far have We Come?CA: A Cancer Journal for Clinicians, 2010
- The opposing roles of Wnt-5a in cancerBritish Journal of Cancer, 2009
- MicroRNAs in CancerAnnual Review of Pathology: Mechanisms of Disease, 2009
- Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor ContextPLOS Biology, 2006
- Wnt-5a Protein Expression in Primary Dukes B Colon Cancers Identifies a Subgroup of Patients with Good PrognosisCancer Research, 2005
- Wnt-5a has tumor suppressor activity in thyroid carcinomaOncogene, 2005